Who owns VERTEX PHARMACEUTICALS INC / MA (VRTX)? Elite investor 13F holders
8 tracked elite investors reported holding VERTEX PHARMACEUTICALS INC / MA as of 2026-06-30, including Renaissance Technologies LLC, D.E. Shaw, Tweedy Browne, Tudor Investment, Gotham Asset Management. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
8 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally. The company offers transformative medicines for people with serious diseases with a focus on specialty markets, such as cystic fibrosis (CF), sickle cell disease (SCD), transfusion dependent beta thalassemia (TDT), and acute pain. It markets TRIKAFTA/KAFTRIO for people with…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Renaissance Technologies LLC | VERTEX PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 158957574.00 USD | 320008.000000 | Shares | reduce | Original filing |
| D.E. Shaw | VERTEX PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 1542347.00 USD | 3105.000000 | Shares | reduce | Original filing |
| Tweedy Browne | VERTEX PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-07 00:00:00 | 19929304.00 USD | 40121.000000 | Shares | reduce | Original filing |
| Tudor Investment | VERTEX PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 14989324.00 USD | 30176.000000 | Shares | buy | Original filing |
| Gotham Asset Management | VERTEX PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 9430916.00 USD | 18986.000000 | Shares | reduce | Original filing |
| Torray Funds | VERTEX PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-07-30 00:00:00 | 7557747.00 USD | 15215.000000 | Shares | reduce | Original filing |
| Bridgewater Associates | VERTEX PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 5396971.00 USD | 10865.000000 | Shares | reduce | Original filing |
| Ancora Advisors / Ancora Holdings | VERTEX PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 559981.00 USD | 1127.000000 | Shares | add | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.